Cybex International, Inc. Announces Results for Third Quarter Ended September 29, 2001; Provides Guidance On Fourth Quarter Results.Business Editors MEDWAY, Mass.--(BUSINESS WIRE)--Nov. 7, 2001 Cybex International, Inc. (AMEX AMEX See: American Stock Exchange : CYB CYB Canada Year Book (Historical Collection) CYB Cayman Brac Island, Cayman Islands (Airport Code) CYB Cover Your Butt CYB Carlsbad Youth Baseball (Carlsbad, California) ), a leading exercise equipment manufacturer, today reported results for the third quarter ended September 29, 2001. Net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight for the quarter were $19,378,000, compared to $31,783,000 for the comparable 2000 period. Net income for the quarter was $173,000, or $0.02 per diluted share, compared to $147,000, or $0.02 per diluted share, for the comparable prior year period. Net sales for the nine months ended September 29, 2001 were $62,841,000, compared to $97,811,000 for the comparable 2000 period. Net income for the nine months ended September 29, 2001 was $574,000, or $0.07 per diluted share, compared to net income before nonrecurring items of $376,000, or $0.04 per diluted share, (or a net loss of $1,483,000, or $0.17 per diluted share, after nonrecurring items) for the comparable 2000 period. Cybex gave guidance that the Company will be profitable for the fourth quarter 2001 and full year 2001. John Aglialoro, Chairman and Chief Executive Officer, stated: "The Cybex team has reported three straight quarters of profit and we anticipate a profitable fourth quarter, despite the declining economy and reduced sales. Management has positioned the Company with a lower cost structure while preparing for the launch of new products." Since the second quarter 2001, the Company has requested that the banks, under its amended Credit Agreement, defer scheduled monthly principal payments under the facility. Since that time, the banks have provided two waivers which extended the due date of these monthly installments and waived through the maturity of the loans any then existing covenant defaults. The most recent principal installment extension expired October 12, 2001 with the result that the Company is currently in arrears Adv. 1. in arrears - in debt; "he fell behind with his mortgage payments"; "a month behind in the rent"; "a company that has been run behindhand for years"; "in arrears with their utility bills" behindhand, behind of approximately $1,688,000 in scheduled principal installments. There is no assurance that the Company will be able to restructure or refinance Refinance 1. When a business or person revises their payment schedule for repaying debt. 2. Replacing an older loan with a new loan offering better terms. Notes: When a business refinances they typically extend the maturity date. the credit facility. However, the Company continues to negotiate with Fleet National Bank and First Union National Bank to restructure the credit facility to extend the maturity date of the loans, waive any defaults and provide a more favorable principal installment schedule, and the Company is actively exploring alternate funding sources, including the total refinancing Refinancing An extension and/or increase in amount of existing debt. of its existing credit facility. Management is optimistic op·ti·mist n. 1. One who usually expects a favorable outcome. 2. A believer in philosophical optimism. op that a satisfactory resolution will be achieved. Cybex International, Inc. is a leading manufacturer of premium exercise equipment for consumer and commercial use. Cybex and the Cybex Institute, a training and research facility, are dedicated to improving exercise performance based on an understanding of the diverse goals and needs of individuals of varying physical capabilities. Cybex designs and engineers each of its products and programs to reflect the natural movement of the human body, allowing for variation in training and assisting each unique user -- from the professional athlete to the rehabilitation rehabilitation: see physical therapy. patient - to improve their daily human performance. For more information on Cybex and its product line, please visit the Company's web site at www.eCybex.com. This news release may contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, uncertainties relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the consolidation of the merged and acquired companies' businesses and uncertainties relating to the implementation of the restructuring plan. Further information on these and other factors which could affect the Company's financial results can be found in the Company's previously filed Reports on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , its Reports on Form 10-Q Form 10-Q See 10-Q. , its Current Reports on Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. , and its proxy statement Proxy Statement A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting. dated April 25, 2001.
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended
September 29, September 30, September 29, September 30,
2001 2000 2001 2000
-------------- ------------- ------------- ------------
Net sales $19,378 $31,783 $62,841 $97,811
Cost of
sales 12,004 20,532 40,649 62,359
Gross profit 7,374 11,251 22,192 35,452
As a percentage
of sales 38.1% 35.4% 35.3% 36.2%
Selling, general and
administrative
expenses 5,828 10,256 18,236 32,746
Nonrecurring
charges -- -- -- 3,152
Operating
income (loss)
before interest
expense 1,546 995 3,956 (446)
Interest expense,
net 1,248 745 2,966 2,068
Income (loss) before
income taxes 298 250 990 (2,514)
Income tax provision
(benefit) 125 103 416 (1,031)
Net income
(loss) $ 173 $ 147 $ 574 $(1,483)
Basic and diluted net income
(loss) per
share $ .02 $ .02 $ .07 $ (.17)
Basic and diluted net
income (loss) per
share before
nonrecurring
items $ .02 $ .02 $ .07 $ .04
Shares used in computing net
income (loss) per
share 8,787 8,749 8,787 8,749
|
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion